CTLA4 and myelodysplastic syndrome: MDS, CMML, and AML patients resistant to epigenetic therapy have been reported to show a trend towards a higher relative increase in PD-1, PD-L1, PD-L2, and CTLA-4 gene expression than patients who achieved a response [65].